Pricing Log in Create free account

Jasper Therapeutics, Inc. (JSPR) vs TScan Therapeutics, Inc. (TCRX)

Jasper Therapeutics, Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. Jasper Therapeutics, Inc. and TScan Therapeutics, Inc. are of similar size ($17.7M and $16.2M). Jasper Therapeutics, Inc. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 14 metrics below, Jasper Therapeutics, Inc. leads on 8 and TScan Therapeutics, Inc. on 6.

Valuation

Metric JSPR TCRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.20 9.71
P/B 9.75 0.43 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.32 0.64
EV/Sales n/m (5.27) 9.21
Earnings yield (331.25%) (395.65%) (33.15%)
Free cash flow yield (437.42%) (396.18%) (25.50%)

Profitability

Metric JSPR TCRX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,695.15%) 0.00%
Net margin 0.00% (1,655.35%) 0.00%
Free cash flow margin 0.00% (1,665.18%) 0.00%
Return on equity (255.05%) (95.80%) (56.36%)
Return on assets (109.05%) (50.09%) (48.04%)
Return on invested capital 0.00% (4,588.23%) 0.00%

Growth

Metric JSPR TCRX Biotechnology median
Revenue growth (TTM) — 2.15% 6.02%
EPS growth (last fiscal year) 19.22% 12.28% 30.26%
Revenue growth, 5-year CAGR — 56.92% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR TCRX Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 1.48 3.37 4.72
Net debt to EBITDA 0.35 0.90 0.96

Dividend

Metric JSPR TCRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JSPR TCRX Biotechnology median
Market cap 17.70m 16.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack